Sign Up to like & get
recommendations!
2
Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.sabcs22-p1-12-06
Abstract: Introduction Tamoxifen, a selective estrogen antagonist, is part of standard adjuvant therapy for hormone receptor-positive breast cancer. In addition to known systemic toxicities, well-described retinotoxic effects include peripheral and macular crystalline deposits, pseudocystic foveal cavitations,…
read more here.
Keywords:
prevalence;
tamoxifen retinopathy;
imaging;
retinal imaging ... See more keywords